Fresenius Medical Care announced today that it will invest $25 million in Humacyte in connection with the merger of Humacyte and a SPAC. Humacyte, which develops implantable human acellular vessels for multiple vascular repair, reconstruction and replacement, entered into a merger with a special purpose acquisition company (SPAC), leading Fresenius to increase its position in […]
Dialysis
Outset Medical beats the Street in Q2, takes ‘interim’ out of CFO’s title
Outset Medical (NSDQ:OM) posted second-quarter results this week that beat the overall consensus on Wall Street. The San Jose, Calif.–based maker of the Tablo is a dialysis machine reported losses of -$30.2 million, or -66¢ per share, on sales of $25.2 million for the three months ended June 30, 2021, for a sales growth of 114.75% […]
Outset Medical CFO to leave, interim replacement named
Outset Medical (NSDQ:OM) announced that CFO Rebecca Chambers will step down and Nabeel Ahmed will take over in an interim capacity. San Jose, Calif.-based Outset said in a news release that Chambers will depart to pursue other opportunities, effective on July 16, 2021. Ahmed, current VP of finance at the company, will assume the role […]
Quanta Dialysis Technologies raises $245M for portable hemodialysis system
Quanta Dialysis Technologies announced that it raised $245 million in an oversubscribed and upsized Series D financing round. Alcester, England/Beverly, Mass.-based Quanta touted the financing as the largest private funding round for a dialysis device company in history, according to a news release. “We are delighted to attract such a strong syndicate of investors, which […]
Outset Medical hires Amazon’s top health AI engineer as its CTO
Outset Medical (NSDQ:OM) announced today that it appointed Jean-Olivier Racine as its new chief technology officer. Racine, a veteran of more than two decades in the technology industry, previously worked as the head of engineering and science for Amazon Web Services (AWS) Health AI, where he managed Amazon Comprehend Medical, Amazon HealthLake and more health […]
Outset Medical appoints Edwards Lifesciences exec Katie Szyman to board of directors
Outset Medical (NSDQ:OM) announced that it appointed Edwards Lifesciences executive Katie Szyman to its board of directors. Szyman currently serves as corporate VP & GM of critical care at Edwards, having spent more than 30 years in leadership roles in the medtech space, according to a news release. Much of her experience came in 23 […]
Outset Medical sales more than triple in Q1
Outset Medical (NSDQ:OM) posted first-quarter results that beat the overall consensus on Wall Street and increased its guidance. The San Jose, Calif.-based Tablo dialysis machine maker reported losses of -$30 million, or -70¢ per share, on sales of $22.9 million for the three months ended March 31, for a sales growth of 218.72% compared with […]
Vascular Therapies touts surgical stenosis treatment trial despite missed primary endpoint
Vascular Therapies announced today that a Phase 3 clinical trial of its Sirogen sirolimus formulation showed encouraging outcomes. Cresskill, N.J.-based Vascular Therapies designed its Sirogen proprietary sirolimus formulation for intraoperative local drug delivery to reduce surgical stenosis in blood vessels. The Phase 3 clinical trial evaluated Sirogen in elderly end-stage renal disease patients, according to a […]
BD lands FDA clearance for hemodialysis catheter
BD (NYSE:BDX) this week said it has received FDA 510(k) clearance for its Pristine long-term hemodialysis catheter. The catheter has a side-hole free symmetric Y-tip distal lumen design that is designed to minimize thrombus adhesion and help facilitate blood clot aspiration prior to hemodialysis treatment. Its symmetric tip is designed to help minimize recirculation rates […]
Outset Medical closes $149.7M public offering
Outset Medical (NSDQ:OM) announced that it closed a previously announced underwritten public offering with proceeds of approximately $149.7 million. San Jose, Calif.–based Outset offered 2.9 million shares of common stock sold by the company itself, plus nearly 3.9 million shares of its common stock sold by certain stockholders at a public offering price of $53.50 per […]
Outset Medical to raise nearly $366M from primary, upsized offerings
Outset Medical (NSDQ:OM) announced today that it priced an underwritten public offering of shares of its common stock. San Jose, Calif.–based Outset — maker of the Tablo hemodialysis system — is offering 2.5 million shares of common stock sold by the company itself, plus more than 3.4 million shares of its common stock sold by […]
